Basic info
Industry
biotechnology research
Sectors
Biotechnology
Life Science
3D cell culture
Biomaterials
Compound testing
Drug Development
Fibrosis Research
Preclinical Models
Stem cell research
Regenerative medicine
IPF
Cancer research
2D cell culture
2D ECM coating
Drug screening
Regenerative Medicine
Disease Models
Organ Transplant
Tissue Engineering
Health Care
Services
Cancer Research
Cancer metastasis
Extracellular Matrix
Fibrosis
ECM scaffolds
NASH
in vitro research tools
Extracellular matrix
Date founded
2016
Funding rounds raised
Total raised
$225K
from 2 investors over 2 rounds
X
Xylyx Bio, Inc. raised $225K on October 22, 2018
Investors: National Heart, Lung, and Blood Institute
X
Xylyx Bio, Inc. raised undisclosed on December 1, 2016
Investors: Boston Harbor Angels Inc.